ImmunoVaccine Inc. | Income Statement
Fiscal year is January-December. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
-
-
129.70
129.70
-
82
Cost of Goods Sold (COGS) incl. D&A
114.90
102.90
-
-
139.90
-
Gross Income
114.90
102.90
-
-
139.90
-
SG&A Expense
5,094.90
7,550.90
8,842.80
7,816.70
12,200.30
21,631
EBIT
5,209.80
7,653.80
8,812.80
7,792.10
12,340.20
21,874
Unusual Expense
-
-
-
195.00
-
-
Non Operating Income/Expense
367.50
1,091.80
122.30
318.00
551.90
104
Interest Expense
70.60
251.90
401.40
1,505.70
966.10
1,385
Pretax Income
4,912.90
6,813.90
9,091.80
9,174.80
12,565.40
22,962
Income Tax
231.50
246.20
317.00
279.00
537.00
1,027
Consolidated Net Income
4,681.40
6,567.70
8,774.80
8,895.80
12,028.40
21,935
Net Income
4,681.40
6,567.70
8,774.80
8,895.80
12,028.40
21,935
Net Income After Extraordinaries
4,681.40
6,567.70
8,774.80
8,895.80
12,028.40
21,935
Net Income Available to Common
4,681.40
6,567.70
8,774.80
8,895.80
12,028.40
21,935
EPS (Basic)
0.22
0.25
0.32
0.29
0.32
0.50
Basic Shares Outstanding
21,489.30
26,059.30
28,710.40
31,602.70
38,656.80
43,767
EPS (Diluted)
0.22
0.25
0.31
0.28
0.31
0.50
Diluted Shares Outstanding
21,489.30
26,059.30
28,710.40
31,602.70
38,656.80
43,767
EBITDA
5,094.90
7,550.90
8,713.10
7,687.00
12,200.30
21,549
Non-Operating Interest Income
-
-
-
-
189.00
401
About ImmunoVaccine
View Profile
